robotics
CORPATH benefits
Proven Patient & Provider Benefit

CorPath GRX is a second generation robotic-assisted PCI system built on the foundation of the CorPath 200’s clinical success with over 3,000 cases across more than 40 cardiovascular programs worldwide.

When using the CorPath System, studies have shown:*

clinical'
Clinical Success in Complex Cases

The CORA-PCI Trial demonstrated 99.1% clinical success in complex cases along with comparable procedure times to manual PCI.1

 
radiation'
Radiation Reduction to Physicians

The PRECISE trial demonstrated a 95% reduction in radiation exposure to the primary operator.2

 
Radiation Reduction to the Patient'
Radiation Reduction to the Patient

A single center retrospective study published in the Journal of Invasive Cardiology demonstrated a 17% reduction in radiation dose to the patient compared to manual PCI.3

 
Stent Usage'
Reduction in Stent Usage

A recent study demonstrated that accurate measurement of coronary anatomy, using CorPath, reduced the use of unnecessary additional stents by 8.3%.4

 

CorPath GRX Delivers Value

Procedural
Control

  • Increase control via robotic-assisted operation of the guide catheter, guidewire, and balloon/stent catheter
  • Enhance workflow with improved bedside features and simplified device exchanges **

Robotic
Precision

  • Position stents exactly where you need them with 1mm movement
  • Optimize stent selection and usage with sub-mm measurement
 

Protection

  • Radiation-shielded cockpit enables procedural control without wearing lead
  • Potential to minimize painful orthopedic injuries
 
 
 

1. Mahmud E, et al. Demonstration of the Safety and Feasibility of Robotically Assisted Percutaneous Coronary Intervention in Complex Coronary Lesions: Results of the Complex Robotically Assisted Percutaneous Coronary Intervention (CORA-PCI) Trial. Presented at SCAI 2016; Orlando, FL.

2. Weisz G, et al. Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE Study. J American College of Cardiol, 2013, Vol 61, No. 15: 1596-1600.

3. Smilowitz N, et al. Robotic-Enhanced PCI Compared to the Traditional Manual Approach. J Invasive Cardiol, 2014;26(7):318-321.

4. Campbell PT, et al. The Impact of Precise Robotic Lesion Length Measurement on Stent Length Selection: Ramification for stent savings. Cardiovasc Revasc Med. 2015;piii:S1553-8389.

* Includes studies conducted using CorPath 200

** Compared to the CorPath 200 System

 
 
close the window

Please complete the form below in order to download the content.








right
close the window

Please complete the form below in order to download the content.







close the window

Please fill out this brief form to subscribe to our email newsletter.





close the window

Please complete the form below and a member of our Clinical team will contact you.






close the window

Please complete the form below in order to download the content.







close the window
Thank you for subscribing to our newsletter. You will now receive email updates from Corindus.